Current Knowledge and Opinions of Medical Trainees Regarding PSA Screening
- PDF / 417,138 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 70 Downloads / 203 Views
Current Knowledge and Opinions of Medical Trainees Regarding PSA Screening Tyler Sheetz 1 & Sabrina Amin 1 & Dinah Diab 1 & Nicolette Payne 1 & Tasha Posid 1 Accepted: 16 October 2020 # American Association for Cancer Education 2020
Abstract After 2008 and 2012 USPSTF recommendations against PSA screening, studies revealed a decline in screening rates and trend towards more advanced disease at presentation. After revision of this recommendation in 2017, PSA screening guidelines remain inconsistent and controversy still exists about its clinical utility. We seek to better understand the knowledge of medical trainees regarding this fundamental controversy and gain better insight into what they are being taught regarding this topic. Participants were medical students (n = 66) and residents (n = 60) from a single institution. REDCap software was used for informed consent, survey distribution, and data collection. Variables measured included PSA clinical knowledge, awareness of the PSA guideline changes, and attitudes, confidence, and viewpoints on use of PSA screening in clinical practice. More than 60% of medical trainees reported little or no knowledge of PSA screening guidelines. Although residents reported more knowledge than medical students, actual assessed knowledge of PSA screening did not differ between groups. Trainees reported receiving education primarily from other healthcare professionals and didactics, with some self-learning online. Though confidence was low overall, residents were more confident than medical students in discussing PSA screening with patients. The majority of respondents wanted more information about PSA testing, with medical students particularly interested in diagnosis/detection, treatment, and survival. Overall, opinions towards PSA testing as an aid were generally positive. Better education about the current PSA screening guidelines for medical trainees is imperative, particularly given that shared decision-making is of great importance when counseling patients on cancer screening. Keywords PSA test . PSA screening . Medical education . Survey study . Prostate cancer
As the most prevalent type of cancer among men in the USA, prostate cancer (PCa) accounts for roughly 10% of cancerspecific mortality. Although these cancers typically are diagnosed later in life (median age 66) and are usually localized, patients presenting as metastatic carry a 5-year survival rate of only 29.8% [1]. PCa is considered a disease amenable to secondary prevention by most clinicians, as screening tools exist to aid in early diagnosis and thus avoidance of advanced presentations. The most widely accepted screening tool is measurement of serum Preliminary data for this project was presented at the Ohio Urological Society and the North Central Section of the American Urological Association annual meetings. * Tasha Posid [email protected] 1
Department of Urology, The Ohio State University Wexner Medical Center, 915 Olentangy River Rd., Suite 3100, Columbus, OH 43212, USA
prostate-specific antigen (PSA
Data Loading...
